Key result
Endomyocardial biopsy provided clear evidence of typical histopathological changes consistent with giant cell myocarditis after cardiovascular magnetic resonance imaging showed indistinguishable patterns.
Why the study?
Giant cell myocarditis is rare and fast-progressing with high risk of poor outcome, but its differentiation from diseases like cardiac sarcoidosis using CMR remains challenging.
Case Report (n=1)
While cardiovascular magnetic resonance imaging is important in evaluating myocarditis, endomyocardial biopsy remains essential for the definitive diagnosis of giant cell myocarditis over cardiac sarcoidosis.
CMR differentiation of GCM from CS remains unreliable in acute presentations; leaves open the need for biopsy-guided diagnosis.
Background: Giant cell myocarditis (GCM) is a rare but often fast-progressing cardiac disease with a high risk of poor outcome. Nonetheless, its differentiation from other diseases like cardiac sarcoidosis (CS) using cardiovascular magnetic resonance imaging (CMR) remains challenging. Case summary: A 27-year-old male patient presented to the emergency department with acute cardiac decompensation and severely reduced left ventricular ejection fraction. After exclusion of an ischaemic cause of heart failure, CMR was performed, showing signs of acute inflammation and late gadolinium enhancement patterns that were indistinguishable between GCM and CS. Despite the suspicion of sarcoidosis based on a lymph node biopsy, endomyocardial biopsy (EMB) provided clear evidence of typical histopathological changes consistent with GCM. An immunosuppressive therapy was initiated leading to an improvement in left ventricular function. Discussion: Cardiovascular magnetic resonance imaging is an important cornerstone in the diagnostic pathway of GCM, however, only complementary use with EMB allows reliable diagnosis. Therefore, full diagnostic and especially prognostic potential of CMR remains unclear but offers an important starting point for optimizing patient management.
No takes yet. Share an insight, caveat, or question.
Gronwald et al. (2025) conducted a case report in Giant cell myocarditis (n=1). Cardiovascular magnetic resonance imaging and endomyocardial biopsy was evaluated on Diagnosis of giant cell myocarditis. Endomyocardial biopsy provided clear evidence of typical histopathological changes consistent with giant cell myocarditis after cardiovascular magnetic resonance imaging showed indistinguishable patterns.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: